CPR.MI
Davide Campari-Milano N.V. [CPR.MI] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CPR.MI Stock Summary
Top 10 Correlated ETFs
CPR.MI
Top 10 Correlated Stocks
CPR.MI
In the News
CPR.MI Financial details
Company Rating
Buy
Market Cap
10.69B
Income
466M
Revenue
3.66B
Book val./share
2.58
Cash/share
0.56
Dividend
0.06
Dividend %
0.64%
Employees
4.5K
Optionable
No
Shortable
Yes
Earnings
27 Feb 2024
P/E
48.8
Forward P/E
-
PEG
12.88
P/S
3.69
P/B
3.75
P/C
16.75
P/FCF
-
Quick Ratio
0.99
Current Ratio
2.03
Debt / Equity
0.75
LT Debt / Equity
0.6
-
-
EPS (TTM)
0.41
EPS next Y
-
EPS next Q
-
EPS this Y
-3.33%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
1.44%
Revenue last 5Y
9.64%
Revenue Q/Q
96.48%
EPS Q/Q
-16.67%
-
-
-
-
SMA20
-4.74%
SMA50
-4.33%
SMA100
-12.98%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
8%
ROC
0.12%
Gross Margin
58%
Oper. Margin
23%
Profit Margin
8%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
8.876-12.96
52W High
-21.83%
52W Low
+17.25%
RSI
56.86
Rel Volume
1.52
Avg Volume
3.73M
Volume
5.66M
Perf Week
3.19%
Perf Month
-0.42%
Perf Quarter
-9.02%
Perf Half Y
-14.57%
-
-
-
-
Beta
0.555
-
-
Volatility
0.16%, 0.22%
Prev Close
2.51%
Price
9.38
Change
4.69%
CPR.MI Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 1.57 | 1.53 | 1.9 | 2.37 | 2.56 | |
| Net income per share | 0.26 | 0.16 | 0.25 | 0.29 | 0.29 | |
| Operating cash flow per share | 0.31 | 0.24 | 0.42 | 0.33 | 0.1 | |
| Free cash flow per share | 0.23 | 0.16 | 0.29 | 0.02 | -0.17 | |
| Cash per share | 0.61 | 0.47 | 0.7 | 0.4 | 0.56 | |
| Book value per share | 2.04 | 1.73 | 2.07 | 2.35 | 2.57 | |
| Tangible book value per share | -0.08 | -0.31 | -0.06 | -0.41 | 0.94 | |
| Share holders equity per share | 2.04 | 1.73 | 2.07 | 2.35 | 2.57 | |
| Interest debt per share | 1.15 | 1.36 | 1.36 | 1.61 | 2 | |
| Market cap | 9.52B | 10.8B | 14.74B | 10.81B | 11.64B | |
| Enterprise value | 10.13B | 11.79B | 15.48B | 12.18B | 13.28B | |
| P/E ratio | 30.88 | 57.47 | 51.74 | 32.47 | 35.23 | |
| Price to sales ratio | 5.17 | 6.09 | 6.78 | 4.01 | 3.99 | |
| POCF ratio | 26.23 | 39.67 | 30.46 | 28.43 | 97.83 | |
| PFCF ratio | 35.14 | 57.6 | 43.61 | 430.83 | -59.31 | |
| P/B Ratio | 3.98 | 5.41 | 6.21 | 4.04 | 3.98 | |
| PTB ratio | 3.98 | 5.41 | 6.21 | 4.04 | 3.98 | |
| EV to sales | 5.5 | 6.66 | 7.12 | 4.52 | 4.55 | |
| Enterprise value over EBITDA | 20.99 | 37.64 | 31.14 | 20.41 | 18.56 | |
| EV to operating cash flow | 27.89 | 43.33 | 32 | 32.02 | 111.56 | |
| EV to free cash flow | 37.36 | 62.9 | 45.8 | 485.34 | -67.63 | |
| Earnings yield | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | |
| Free cash flow yield | 0.03 | 0.02 | 0.02 | 0 | -0.02 | |
| Debt to equity | 0.55 | 0.77 | 0.65 | 0.67 | 0.75 | |
| Debt to assets | 0.27 | 0.34 | 0.3 | 0.3 | 0.33 | |
| Net debt to EBITDA | 1.25 | 3.17 | 1.49 | 2.29 | 2.28 | |
| Current ratio | 1.49 | 2.06 | 2.02 | 2 | 1.98 | |
| Interest coverage | 9.38 | 9.02 | 14.11 | 16.24 | 7.57 | |
| Income quality | 0.94 | 1.17 | 1.21 | 0.74 | 0.36 | |
| Dividend Yield | 0.01 | 0.01 | 0 | 0.01 | 0.01 | |
| Payout ratio | 0.19 | 0.33 | 0.22 | 0.2 | 0.2 | |
| Sales general and administrative to revenue | 0.01 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Intangibles to total assets | 0.51 | 0.52 | 0.48 | 0.52 | 0.28 | |
| Capex to operating cash flow | -0.25 | -0.31 | -0.3 | -0.93 | -2.65 | |
| Capex to revenue | -0.05 | -0.05 | -0.07 | -0.13 | -0.11 | |
| Capex to depreciation | -1.28 | -1.09 | -1.83 | -3.93 | -2.86 | |
| Stock based compensation to revenue | 0 | 0.01 | 0.01 | 0.01 | 0 | |
| Graham number | 3.48 | 2.51 | 3.4 | 3.93 | 4.09 | |
| ROIC | 0.09 | 0.06 | 0.07 | 0.08 | 0.08 | |
| Return on tangible assets | 0.13 | 0.09 | 0.11 | 0.12 | 0.07 | |
| Graham Net | -0.98 | -1.23 | -1.11 | -1.83 | -1.86 | |
| Working capital | 564.4M | 799.8M | 965.5M | 924.4M | 1.19B | |
| Tangible asset value | -89.4M | -357.5M | -70.3M | -469.6M | 1.08B | |
| Net current asset value | -732.1M | -1B | -808M | -1.48B | -1.33B | |
| Invested capital | 0.55 | 0.77 | 0.65 | 0.67 | 0.75 | |
| Average receivables | 331.8M | 358.15M | 346.3M | 370.1M | 432.75M | |
| Average payables | 228.35M | 280.95M | 357.9M | 468.15M | 531.4M | |
| Average inventory | 592.3M | 637.65M | 701.25M | 875.05M | 1.14B | |
| Days sales outstanding | 74.8 | 69.77 | 59.45 | 52.27 | 59.93 | |
| Days payables outstanding | 121.82 | 157.16 | 164.44 | 178.27 | 150.91 | |
| Days of inventory on hand | 313.07 | 321.31 | 310.79 | 330.51 | 367.43 | |
| Receivables turnover | 4.88 | 5.23 | 6.14 | 6.98 | 6.09 | |
| Payables turnover | 3 | 2.32 | 2.22 | 2.05 | 2.42 | |
| Inventory turnover | 1.17 | 1.14 | 1.17 | 1.1 | 0.99 | |
| ROE | 0.13 | 0.09 | 0.12 | 0.12 | 0.11 | |
| Capex per share | -0.08 | -0.07 | -0.13 | -0.31 | -0.28 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.61 | 0.6 | 0.7 | 0.66 | 1.29 | |
| Net income per share | -0.12 | 0.12 | 0.07 | 0.12 | 0.1 | |
| Operating cash flow per share | 0.25 | -0.03 | -0.08 | 0 | 0.18 | |
| Free cash flow per share | 0.1 | -0.07 | -0.16 | 0 | -0.01 | |
| Cash per share | 0.4 | 0.57 | 0.57 | 0 | 0.56 | |
| Book value per share | 2.37 | 2.54 | 2.52 | 0 | 2.58 | |
| Tangible book value per share | -0.42 | -0.23 | -0.22 | 0 | 0.95 | |
| Share holders equity per share | 2.37 | 2.54 | 2.52 | 0 | 2.58 | |
| Interest debt per share | 1.61 | 1.82 | 1.98 | 0 | 1.98 | |
| Market cap | 10.68B | 12.6B | 14.35B | 12.64B | 11.6B | |
| Enterprise value | 12.05B | 11.97B | 15.95B | 0 | 13.23B | |
| P/E ratio | -19.98 | 23.57 | 43.06 | 23.32 | 25.52 | |
| Price to sales ratio | 15.44 | 18.86 | 18.16 | 17 | 7.94 | |
| POCF ratio | 37.92 | -344.68 | -159.4 | 0 | 55.48 | |
| PFCF ratio | 90.84 | -155.53 | -77.67 | 0 | -999.63 | |
| P/B Ratio | 3.99 | 4.43 | 5.04 | 0 | 3.96 | |
| PTB ratio | 3.99 | 4.43 | 5.04 | 0 | 3.96 | |
| EV to sales | 17.42 | 17.93 | 20.19 | 0 | 9.06 | |
| Enterprise value over EBITDA | 1.98K | 76.76 | 83.46 | 0 | 41.63 | |
| EV to operating cash flow | 42.78 | -327.61 | -177.2 | 0 | 63.3 | |
| EV to free cash flow | 102.48 | -147.83 | -86.35 | 0 | -1.14K | |
| Earnings yield | -0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Free cash flow yield | 0.01 | -0.01 | -0.01 | 0 | 0 | |
| Debt to equity | 0.67 | 0.71 | 0.78 | 0 | 0.75 | |
| Debt to assets | 0.3 | 0.3 | 0.34 | 0 | 0.33 | |
| Net debt to EBITDA | 224.31 | -4 | 8.38 | 0 | 5.14 | |
| Current ratio | 2 | 2.03 | 2.03 | 0 | 1.98 | |
| Interest coverage | 15.95 | 10.03 | 15.67 | 0 | 5.24 | |
| Income quality | 2.1 | -0.34 | -0.41 | 0 | 1.84 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | -0.07 | 0.25 | 0.81 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Intangibles to total assets | 0.52 | 0.47 | 0.47 | 0 | 0.28 | |
| Capex to operating cash flow | -0.58 | 1.22 | 1.05 | 0 | -1.06 | |
| Capex to revenue | -0.24 | -0.07 | -0.12 | 0 | -0.15 | |
| Capex to depreciation | -3.39 | -2.05 | -1.85 | 0 | -3.75 | |
| Stock based compensation to revenue | 0.01 | 0.01 | 0.01 | 0 | 0 | |
| Graham number | 2.52 | 2.61 | 2.04 | 0 | 2.41 | |
| ROIC | -0.22 | 0.03 | 0.02 | 0 | 0.04 | |
| Return on tangible assets | -0.05 | 0.04 | 0.02 | 0 | 0.02 | |
| Graham Net | -1.85 | -1.97 | -1.86 | 0 | -1.86 | |
| Working capital | 924.4M | 1.24B | 1.24B | 0 | 1.19B | |
| Tangible asset value | -469.6M | -253.5M | -253.5M | 0 | 1.08B | |
| Net current asset value | -1.48B | -1.34B | -1.34B | 0 | -1.33B | |
| Invested capital | 0.67 | 0.71 | 0.78 | 0 | 0.75 | |
| Average receivables | 347.4M | 410M | 497.45M | 0 | 0 | |
| Average payables | 541.7M | 545.6M | 549.5M | 0 | 0 | |
| Average inventory | 1B | 1.13B | 1.25B | 0 | 0 | |
| Days sales outstanding | 50.25 | 58.44 | 63.94 | 0 | 29.52 | |
| Days payables outstanding | 155.51 | 177.83 | 160.88 | 0 | 71.63 | |
| Days of inventory on hand | 288.32 | 404.05 | 365.53 | 0 | 174.42 | |
| Receivables turnover | 1.79 | 1.54 | 1.41 | 0 | 3.05 | |
| Payables turnover | 0.58 | 0.51 | 0.56 | 0 | 1.26 | |
| Inventory turnover | 0.31 | 0.22 | 0.25 | 0 | 0.52 | |
| ROE | -0.05 | 0.05 | 0.03 | 0 | 0.04 | |
| Capex per share | -0.15 | -0.04 | -0.08 | 0 | -0.19 |
CPR.MI Frequently Asked Questions
What is Davide Campari-Milano N.V. stock symbol ?
Davide Campari-Milano N.V. is a IT stock , located in Sesto san giovanni of Mi and trading under the symbol CPR.MI
What is Davide Campari-Milano N.V. stock quote today ?
Davide Campari-Milano N.V. stock price is $9.38 today.
Is Davide Campari-Milano N.V. stock public?
Yes, Davide Campari-Milano N.V. is a publicly traded company.
Company Profile
- Volume Average 3.73M
- Market Capitalization 10.69B
- Employee 4.5K
- CEO Mr. Robert Kunze-Concewitz
- Headquarters Sesto San Giovanni,MI,IT
- IPO Date 2001-07-06
-
Website
https://www.camparigroup.com 
Davide Campari-Milano N.V., together with its subsidiaries, markets and distributes alcoholic and non-alcoholic beverages in the Americas, the Middle East, Africa, Europe, and the Asia-Pacific. It offers range of spirits categories, including aperitif, vodka, liqueurs, bitters, whisky, tequila, rum, gin, and cognac, as well as champagne and non-alcoholic aperitif under various brands, such as Aperol, Campari, SKYY, Wild Turkey, Grand Marnier, Appleton Estate, Wray & Nephew Overproof, and other brands. The company was founded in 1860 and is headquartered in Sesto San Giovanni, Italy. Davide Campari-Milano N.V. is a subsidiary of Lagfin S.C.A., Société en Commandite par Actions.
